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INTRODUCTION 
 The advent of mechanical ventilation in the 1960’s and 70’s revolutionized the 
approach to newborn illness and improved infant mortality significantly.1 Neonatal 
intensive care has developed into an entire medical specialty using tools such as 
surfactant replacement and extracorporeal membrane oxygenation to bring sick infants 
through the perilous first few days of life.  
For much of the world through, access to these advances is still many years away. 
If we consider India, where the project was conceived, mechanical ventilation arrived in 
there in the early 1990’s2, but its advantages have not been shared throughout the country. 
Describing the situation from a critical care center in New Delhi, Nangia et al comment 
that mechanical ventilation “is an expensive and complex technique and a large 
investment in terms of money, time, skill, and labor…” 2 Rough estimates postulate that 
80% of India’s population lives in areas lacking adequate intensive care services. 3 
India’s population in 2009 was estimated to be 1.15 billion people4 leaving roughly 920 
million people without access to intensive care.  
Using India’s crude birth rate of 32 per 1000 people  (as of 2010)5 that would 
mean that 29.4 million children are born every year without access to state-of-the-art 
ventilation. If you consider respiratory distress syndrome (RDS) alone, 2-3% of all 
neonates will require mechanical ventilation.6, 7 Combining RDS with sepsis and 
meconium aspiration syndrome, that number could easily be 5-10%. If 5% of all infants 
born to resource-poor areas of India that lack access to mechanical ventilators require 
ventilation that represents a burden of disease of 1 million people a year, for India alone.  
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 From personal experience, in rural areas where ventilation is not available the 
solution is use manual intermittent positive pressure ventilation (IPPV). In lay terms, 
parents are required to “hand bag” newborns using an ambu bag for days on end as their  
only means of respiration. Ambu bags8 are self-
inflating air reservoirs that are typically used for 
temporary ventilation during cardio-pulmonary 
resuscitation (CPR) or neonatal resuscitation. 
When they are the only means available for 
ventilation, parents are typically taught to squeeze 
the bag with some sort of rhythm. One could 
imagine that fatigue, hunger, conversations, anxiety, and boredom make this 
responsibility quite daunting.   
 Project Tiger Breath is a program designed to create and deliver a low-cost form 
of mechanized ventilation to hospitals in the developing world. I say mechanized 
ventilation rather than mechanical ventilation because I do not want to suppose that the 
device should create the illusion that it offers all of the same features common to 
mechanical ventilation like air filtering, fraction of inspired oxygen (FIO2) control, 
precise pressure and volume settings, and many more.  
By discussing the need for new technology, one crosses over from the world of 
non-governmental organizations (NGOs) and public health into a world of design, 
manufacturing, and distribution. Often these two worlds find it difficult to communicate, 
but there is hope that collaboration can reverse this.9, 10  
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 The creation and distribution of medical devices is driven by supply and demand. 
However, many common medical devices have not been able to penetrate global markets 
because “without money, need does not translate into demand.”10 Without a sizeable 
demand in a well-defined market, companies are reluctant to invest in new medical 
devices. Because of this Project Tiger Breath is a university-based program that will rely 
on public-private partnerships in order to translate the ingenuity and resources of 
university students and faculty into health outcomes for low resource areas.   
Project Tiger Breath is program that is intended to organize and oversee the 
design, manufacturing, distribution, and use of the Tiger Breath Ventilation Assist Device 
(VAD). The program will coordinate the efforts of several “partners” including 
university-based design teams, clinical advisors, international practitioners, and funders, 
as well as manufacturing, distribution, and advertising companies. The program will be 
lead by a project manager that acts as the intermediary between all of the program 
partners.  
Project Tiger Breath began through a partnership with the Mechanical 
Engineering Department at Clemson University during the fall of 2010. The project 
manager presented the mission and vision to the students at the beginning of the semester 
and charged them with creating a device that was low-cost, small, lightweight, safe, and 
durable that could take the place of a parent’s need to provide manual support. What they 
created was an electrical motor driven cam-follower system that uses interchangeable 
cams to control the ventilation parameters for the device.  
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Figure 2. Tiger Breath VAD Clemson Prototype 
 
The following is a discussion of the program plan and evaluation for Project Tiger 
Breath. It is will be presented in three parts. The first part is a systematic review of the 
literature that discusses similar programs that have developed devices for low-resource 
settings. The next part is a detailed description of the program plan that includes the 
program theory, goals and objectives, logic model, and implementation plan. The third 
part outlines a plan for evaluation that will be used to monitor the success of Project 
Tiger Breath over time. Finally, the conclusion of the paper will discuss Project Tiger 
Breath within the context of global device design and manufacturing and the implications 
for future directions.  
 A consistent theme through out this discussion of Project Tiger Breath will be to 
highlight the importance of collaboration and partnership as key to developing successful, 
innovative programs in the twenty-first century. Too often, the worlds of engineering and 
public health fail to interact in an optimal way that combines the talents of both groups 
and mediates their individual inadequacies. Project Tiger Breath also takes into account 
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the fact that design and program planning are not all that are necessary to deliver a new 
medical device. The collaborative mindset seen in the early stages of design and testing 
will carry over in the later stages of the program as Project Tiger Breath networks with 
partners in advertising, distribution, graphic design, management and many others.  
 This discussion is important because it provides the framework for insuring that a 
new device will be accepted in the market. It will build off of the examples found in the 
systematic review and use the tools of program planning and evaluation to in a sense 
“rethink” how university-based global partnerships that cross the boundaries of culture 
and commerce can cooperate to build a new medical devices to supply the places of 
greatest need.  
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SYSTEMATIC REVIEW 
INTRODUCTION 
 The following systematic review focuses on gaining a knowledge base to guide 
the development, implementation, and evaluation of the Tiger Breath Ventilation Assist 
Device. Project Tiger Breath will need to meet several guiding tenants if the project is to 
be deemed successful. It is essential that the following elements be addressed from the 
outset of the program plan.  
1. The intervention must not harm infants, and should produce better outcomes than 
current interventions for neonates in low-resource settings. 
2. The intervention must be low-cost so that it is readily obtainable in the target area 
either through hospital funding, NGO purchase orders, or private payers. 
3. The intervention must be culturally and professionally relevant so that it honors 
the efforts of health care providers by respecting their desire for professional 
equipment.  
4. The intervention must be sustainable so that the Tiger Breath VAD does not 
become irrelevant a short time after purchase. 
  
To accomplish these objectives, several questions needed to be addressed.  
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METHODS 
RESEARCH QUESTIONS. The systematic review of the literature sought to answer three 
distinct questions that would lay the foundation for implementing Project Tiger Breath.   
• What is the burden of neonatal illness requiring mechanical ventilation in low-
resources areas of the world, particularly Asia? 
• Have similar devices been invented that are intended to increase access to 
mechanical ventilation? 
• How have other devices and their programs that address other health problems 
been designed, implemented and evaluated for use in low-resource settings? 
SEARCH STRATEGY. PubMED served as the online database used to identify relevant 
studies that address the three research questions above. To ensure thoroughness, I used 
MeSH terms in the search strategy wherever possible in order to capture the appropriate 
categories within PubMED. Applicable MeSH terms included respiration, artificial; 
developing countries; infant, newborn; intensive care, neonatal; and equipment design. 
The following search strategies where used to identify potentially relevant articles: 
• "developing countries"[MeSH] AND "equipment design"[MeSH] AND "infant, 
newborn"[MeSH] 
o 8 articles 
• "low-cost" AND "developing countries"[MeSH] AND "infant, newborn"[MeSH] 
o 46 articles 
• "respiration, artificial”[MeSH] AND "developing countries"[MeSH] AND 
"infant, newborn"[MeSH] 
o 24 articles 
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• "low-cost" AND (ventilation OR ventilator) AND "developing countries"[MeSH] 
o 6 articles 
• "low-cost" AND (ventilation OR ventilator) AND "developing countries"[MeSH] 
AND "infant, newborn"[MeSH] 
o 2 articles 
• "low-cost" AND "equipment design"[MeSH] AND "developing 
countries"[MeSH] AND "infant, newborn"[MeSH] 
o 1 article 
• "low-cost" AND "equipment design"[MeSH] AND "developing 
countries"[MeSH] 
o 18 articles 
 
I reviewed the title of each of these 105 articles, recognizing many of them to be repeated 
in the similar searches. If the title of the article seemed appropriately relevant to one of 
the three research questions, I reviewed the abstract as well. Inclusion criteria for a study 
were as follows: 
• The article must represent information that is relevant to one of the three research 
questions. 
• The data must come from developing countries. 
• It must be written in English. 
• The article should be available within the University of North Carolina at Chapel 
Hill’s online library. (Two articles were purchased using intralibrary loan, but 
the return on each $5 investment limited the ability to purchase more.) 
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I conducted a hand search of the reference list for relevant articles as well as the “similar 
articles” feature in the PubMED database. In all, I thoroughly reviewed 35 articles  Much 
of the information from the articles related to burden of suffering related to neonatal 
ventilation was reported in the INTRODUCTION section of this paper. I found no similar 
device that could provide supplemental ventilation to a newborn in the published 
literature. Four studies describing low-cost devices were found that also had intervention 
plans discussed. A summary of each of these studies can be found below.  
SUMMARY OF LOW-COST DEVICE INTERVENTIONS 
BEYOND THE WHEELCHAIR-THE SKEETER 
 The Biomedical program at the University of Alaska11 recognized that in many 
developing countries individuals that are disabled are restrained from living otherwise 
productive lives because they lack access to wheelchairs that are capable of functioning 
in settings where there are poor roads.11 The solution they designed was a wheelchair 
carriage that was motorized, but was made of bicycle parts and a low-cost custom frame 
that could be feasibly maintained in a low-resource area. They focused on Cambodia, a 
country that has experienced years of conflict and civil war leaving many of its citizens 
disabled from devastating injuries. 
 Disability is a problem that is experienced far too often in the developing world. 
The WHO “estimates that up to 10% of the world’s population has a disability, and 80% 
of those people life in developing countries.”11  Lack of transportation for these people is 
an almost independent predictor of poverty. Without transportation, individuals are 
restricted to a lifetime of begging “because it is generally difficult to impossible to gain 
access to vocational training, rehabilitation, or even the most meager employment.”11   
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 Their study focused primarily on the design of the device, giving a fair amount of 
attention to making it sustainable in the developing world. Their guiding principles 
included the following: 
• Inexpensive (less than $250) 
• Manufacturable in target countries 
• Repairable 
• Applicable to a variety of impairments 
• Useful 
• Safe 
 To accomplish this, they changed their 
focus from using motorcycle parts to using 
components that were also used with bicycles, 
which are ubiquitous in developing countries. 
They also implemented cost-saving measures like using local manufactures and local 
techniques to build the device, along with purchasing parts from nearby countries like 
China or India. One of the biggest cost-saving opportunities was to use local labor for 
production. They ensured the safety of the device by limiting the maximum speed, adding 
a secure rear gate, and widening the wheelbase to avoid rollovers. 
 For the distribution of the device, the authors proposed three avenues of funding: 
private donations from interest groups in wealth nations, NGOs that are currently 
purchasing less useful devices, and micro-loans that are given to the individual and are 
repaid after the person has obtained stable income.  
volume of production the cost per engine will
become lower.
Using local labour and resources to manufacture
the Skeeter ensures it can be repaired locally as
well. This is a significant point since many
previous efforts to provide technology, such as
wheelchairs, to people with disabilities in develop-
ing countries have been flawed because the
donated devices were impossible to repair by the
recipients or local craftsmen [11].
The Skeeter is designed to allow wheelchair users
to travel independently. The Skeeter can be used by
full time wheelchair users and others who need a
stable vehicle, including amputees and those with
balance problems or weakness due to polio, leprosy,
or various other debilitating conditions. In many
cases the latter group of people cannot negotiate the
use of a two-wheeled motorbike and may require a
stable means of transportation that can be operated
entirely with hand controls.
The Skeeter can be readily adapted for a disabled
individual who does not use a wheelchair but needs
the stability of a three wheeled vehicle and a seat to
support them while they travel. The seat (not
depicted in Figure 2) will fold down from one side
of the frame to readily deploy.
One of the most important safety features of the
Skeeter is that its maximum speed is quite slow,
approximately 20 km/h. This is not a significant
problem since much of the rural traffic is side-of-the-
road carts pushed or pulled by humans or animals.
To ensure lateral stability the wheelbase in the rear is
fairly wide (about 52 inches) and the rider’s centre of
gravity is positioned directly between them.
A four-wheeled design might provide greater
lateral stability, but would require additional parts
not available from bicycles, including a tie rod, tie
rod ends, and a ball and socket steering arm, plus an
additional tire and wheel. The steering linkage parts
are expensive and would readily render the Skeeter
too costly for use in poor countries where every
dollar counts.
An important safety feature is the wheelchair lock
down system (Figure 2). The front of the wheelchair
frame which connects to the footrests is cradled by
adjustable receptacles from each side, and the rear
entry gate closes tightly against the upper rear
quadrant of the rear wheelchair tires. This config-
uration prevents movement of the wheelchair in all
possible directions and is very secure. Other lock-
down configurations can be implemented when the
local wheelchairs vary from the conventional style, as
they often do in developing countries (Figure 3).
Purchase and distribution of skeeters
While the price of a Skeeter may appear trivial to
those in the western world, it is likely to be too
expensive to be purchased outright by the poverty-
ridden disabled people who need them most. There-
fore it appears likely that alternative mechanisms will
be needed to provide Skeeters to the target popula-
tion. There are at least three mechanisms to achieve
this goal.
The first is the simplest and most direct. Funds
can be raised in wealthy countries specifically for the
purchase of these devices and each Skeeter purchased
can be donated to a worthy individual within the
mobility-impaired population.
Second, there are many Non-Governmental Or-
ganizations (NGOs) in developing countries that
Figure 2. Details of the Skeeter.
Figure 1. The original sidecar adaptation operated by a
Cambodian amputee.
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 This device would not require any sort of implementation trial because it is not 
technically a “medical device.” The authors had collaborators in Cambodia that were 
ready to proceed with manufacturing and distribution.  The authors do not provide any 
information regarding an evaluation plan.  
RECYCLED INCUBATORS AS ALTERNATIVES FOR MODERN SYSTEMS 
 This study took place in Nigeria, in conjunction with the bioengineering 
department at Imperial College in London, England. They sought to address the need for 
neonatal incubators in Nigerian hospitals by recycling older incubators that were no 
longer used in the Nigerian hospitals. They identified the need for incubators by 
interviewing clinicians and administrators in the local hospitals, rather than coming up 
with their own idea.  
 The researchers 
identified that “it is difficult if 
not impossible for neonatal 
centres in developing countries 
to purchase modern systems.”12 
The developed a technique to 
use parts from obsolete 
incubators and make digitally 
controlled systems that would be similar to modern systems. Using nineteen 
dysfunctional and obsolete incubators from Nigerian hospitals, they were able to 
reconstruct them with the new design onto sixteen units divided across four NICUs in 
Nigeria. Before the manufacturing ever started they searched the global market (via the 
(defined as ease of availability of system’s
spare parts and maintenance engineers in
Nigeria), (c) ease of hood accessibility, (d)
heating transient response, (e) sensitivity
and response to erratic power supply, (f)
humidification, (g) system aesthetic
FIG. 1. Recycling assembly block diagram.
FIG. 2. Mean scores of performance indices for modern (&) and recycled incubators (%): (a) set-point accuracy,
(b) maintainability (defined as ease of availability of system’s spare parts and maintenance engineers in Nigeria), (c)
ease of hood accessibility, (d) heating transient response, (e) sensitivity and response to erratic power supply, (f)
humidification, (g) system aesthetic appreciation, (h) operation inherent noise, (i) response to high ambient
temperature and (j) cost of system procurement.
Recycled incubators 209
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Internet) for the lowest price of components that could not be salvaged, organized an 
engineering team, and established their design criteria.  
 The recycled devices were tested for 6 months and subject to “rigorous 
performance characterization.” 12 Their performance was compared to a cohort of modern 
incubators that the researchers also supplied to the hospitals using a 10-point scale that 
measured ten performance characteristics.  
• Set-point accuracy 
• Maintainability 
• Ease of hood accessibility 
• Heating transient response 
• Sensitivity and response to erratic power supply 
• Humidification 
• System aesthetic appreciation 
• Inherent noise during operation 
• Response to high ambient temperature 
• Cost of system procurement 
 The overall performance scores for the recycled and the modern incubators were 
the same (65.9% vs. 65.8%). The areas where the recycled incubators were the most 
different were aesthetic appreciation and cost of procurement. These two obviously go 
hand-in-hand, but the very good cost scores could easily outweigh (but not negate) the 
poor aesthetics. Overall, the recycled incubators were much more affordable, 
maintainable, and responsive making them a more cost-effective solution for the Nigerian 
hospitals.   
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 The authors concluded that the use of outdated incubators in developing countries 
presented a significant risk to newborn children; however their study showed that with a 
few modifications those old incubators could be recycled and be as effective and safe as 
other more expensive incubators that are not practical even for tertiary care centers to 
purchase. The authors do not report any attempt to evaluate their program or their plan 
choosing to focus only on the device.  
COLOR-CODED SCALE FOR LOW-BIRTH WEIGHT INFANTS 
 This medical device originated from the Bloomberg School of Public Health at 
Johns Hopkins University.13 The intention was to make a device that could easily and 
accurately delineate newborns that were !2500 g, 2000-2499 g, and "2000 g in 
developing countries where access to scales may be limited. The information gained from 
the delineation helps to classify newborns into the 
appropriate risk category so that they can receive 
proper treatment.  
 This particular study reports the design 
and implementation of the BirthWeigh III that 
was developed in conjunction with the Program 
for Appropriate Technology in Health (PATH). 
The first and second models had failed to be 
sensitive and specific enough to be implemented.  
 In this region of Nepal, 95% of the children are born at home. The BirthWeigh 
device is designed to be used in homes by birth attendants and was analyzed within a 
larger study that was taking place in Nepal. Infants were weighed at home by the project 
Training for project workers (n=11) included a manual
with written and pictorial instructions on use of the scale,
and practice sessions using hand made, life size dolls of
varying weights. All workers were observed directly and given
constructive feedback and advice during the first week of
household visits by one of the authors (LCM).
Subjects for this study were recruited consecutively among
infants enrolled in the parent trial. The required sample size
(n=1070) was based on the number of infants necessary to
estimate sensitivity of the device to within 5%, assuming 30%
prevalence of infants ,2500 g (based on data from the
previous year), type I error equal to 5%, and minimum
sensitivity of 70%. The final sample was slightly increased as
security problems in the study area prevented timely
estimates of the ongoing enrolment figures.
Workers obtained informed consent from the mother, then
placed the infant in a sturdy cloth sling with two reinforced
holes through which the hook at the end of the spring scale
was attached. The worker raised the infant secured in the
sling and observed the level of the indicator button at the top
of the scale (fig 1B). If the button remained below the top
level of the plastic cylinder, the worker classified the infant as
having a weight of >2500 g. If the first step on the indicator
button could be seen or felt with the worker’s thumb, the
infant was classified into the 2000–2499 g category. If
the entire indicator button was exposed or detected by feel,
the weight class was recorded as ,2000 g. The steps on the
indicator button were colour and shape coded, and the
recording area on the data collection form was coded with
matching colours and shapes. Thus, neither literacy nor
vision was required for use of the scale.
Statistical analysis
Infants with data for both the BirthWeigh III and digital
scales were included in the analysis. Gold standard birth
weight categories were created from the continuous weight
measurements recorded using the digital scale. Sensitivity,
specificity, and predictive values for the test device were
estimated. All analyses were conducted using Stata version
8.0 (StataCorp., College Station, TX).
Ethical approval
This study was approved by the Nepal Health Research
Council, the Committee on Human Research of the Johns
Hopkins Bloomberg School of Public Health, and the PATH
Human Subjects Protection Committee.
RESULTS
Between 5 March and 30 June 2004, 1820 paired measure-
ments using the BirthWeigh III and Seca Scales were
recorded (fig 2), on average 10 minutes apart. Ninety per
cent of infants were measured within 72 hours and 97%
within the first week of life. According to the gold standard
scale, there were 1309, 421, and 90 infants in the three
weight categories, >2500, 2000–2499, and ,2000 g, respec-
tively, for a total LBW prevalence estimate of 28.1% (95% CI
26.0% to 30.1%). No infants >2500 g were classified into the
lowest weight category using the BirthWeigh III device, and a
single infant of ,2000 g was misclassified into the highest
BirthWeigh III weight category. All other misclassifications
were between adjacent categories. The sensitivity, specificity,
and positive and negative predictive values of the BirthWeigh
III device for identification of LBW infants and infants
,2000 g are shown in table 1.
Only seven infants weighing >2000 g were misclassified
by the BirthWeigh III scale as ,2000 g, and among these
seven misclassified infants, six were within 60 g of the cut-
off. Among the 11 infants ,2000 g not detected as such by
the BirthWeigh III device, nine were within 80 g of the cut-
off. For classification of LBW, 2 of the 11 scales (#9 and#11)
accounted for 21 of the 32 false negatives, and a third scale
(#6) accounted for half (16/31) of the false positives.
DISCUSSION
The lightweight, portable, hand held, coil spring BirthWeigh
III scale accurately classified newborns into one of three
weight categories. For identification of LBW infants, the scale
performed significantly better (94% sensitivity and positive
predictive value) than predicted under most classification
rules based on anthropometric measures. When rules have
been adjusted to increase sensitivity to levels seen in this
study, specificity has suffered considerably, reducing the
positive predictive value of anthropometric surrogates to
unsatisfactory levels.7 8 12 22 23 In settings where infants
categorised as LBW or ,2000 g are referred to the next level
health care centre, or are given weight dependent interven-
tions, maintaining high specificity while still detecting a
maximal proportion of at-risk infants is imperative.
The BirthWeigh III scale offers the facility to classify
infants into multiple weight categories without significant
loss of validity, thus extending its potential use to weight
dependent interventions such as antibiotic4 and topical
emollient therapy24 25 or vitamin A dosing.26 The detection
rate (87.8%) for infants ,2000 g was higher than the overall
detection rate for all LBW infants with the previous version of
the scale.20 Furthermore, this device will be more affordable
than previous low cost scales, due to the emphasis during its
design on simplicity and construction from inexpensive
materials.
While the hand held scale operators also recorded the birth
weight using the gold standard digital scale, any potential
Figure 1 BirthWeigh III scale. (A) Drawing displaying the colour coded
button providing tactile and visual indication of birth weight category.
(B) Project worker weighing an infant with the scale. Informed consent
was obtained for publication of this figure.
Low cost spring scale to identify LBW infants 411
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workers and then with a digital scale. The device itself is lightweight, composed of only 
four main parts, and made of inexpensive materials. It’s estimated costs is only $5.00 
USD. Other costs included training 11 project workers and providing a written and 
pictorial manual. 
 The trial was nested in a larger parent trial containing 1070 newborns. As a result, 
none of the !2500 g babies (28%) were classified wrongly into the lowest category, and 
only 1 "2000 g infant was inappropriately labeled as !2500 g. In all, only “seven infants 
weighing !2000 g were misclassified…as <2000 g, and…six were within 60 g of the 
cutoff.”13  Eleven infants that were <2000 g failed to be detected that should have been 
detected. The specificity of the BirthWeigh III (the ability to identify a truly <2000 g 
infant) was 99.6 with positive and negative predictive values of 91.9 and 99.4, 
respectively. 13  The researchers concluded that this study proved that the BirthWeigh III 
was a suitable device that could safely identify children that are low-birth weight at a low 
cost that could be obtainable in a developing country.  
PHOTOTHERAPY USING LEDS 
 The Duke-Engineering World Health (EWH)14 program sends 50 or more 
engineers around the world every year. One device reported in April 2010 was a new 
solution to an old problem—neonatal jaundice. Phototherapy has been the mainstay for 
treatment for neonatal jaundice/hyperbilirubinemia for many years in the developed 
world, but this technology costs between $3000 and $5000 USD and has remained out of 
reach for most of the developing world. Many of these machines are available to be 
donated around the world, but the bulbs alone (which last for two to three months) can 
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put them out of reach for most hospitals. The solution was to invent an LED-based device 
that was powered by a car or motorcycle battery.  
 The design process began with a series of interviews conducted with medical 
doctors working in villages, asking them what relevant technology would be most helpful 
to them. After selecting phototherapy as the focus project for 2005, they identified that 
the lack of replacement bulbs and power supply were the most common causes of device 
failure. The project incorporates students that take a class at Duke that provide initial 
designs that are later provided to the public for improvement. For this project, a public 
design firm, Tackle Design, took on the project and refined it.  
 The team consulted US physicians and incorporated the thoughts of many 
different professionals into the final design of the device. After taking into consideration 
all the design input, the team conducted bench tests to evaluate the device’s performance 
in critical aspects of the design like battery life, light source characteristics, and longevity.   
Next, the team proceeded to field trials, 
implementing 114 units divided amongst 
four countries in hospitals ranging from 
very small to very large. Two engineers 
went with every device to help install the 
device, train the staff, and conduct follow-
up interviews. The final cost of the device 
was $65.62 USD, which is dramatically less than the multi-thousand dollar units that are 
commercially available. From the first trial, the field teams noted one important concern. 
First, the staff in the hospitals complained that parts of the device looked “homemade” 14 
Bench Testing
The devices were bench tested to determine that they met the
specifications. Figure 3 summarizes the most critical data from
bench testing, showing the intensity of light for each square
inch of the illuminated crib, following the methods suggested
by Vreman [8]. All of the designs tested in each of the field tri-
als passed all bench testing andmet all design specifications.
Field Engineering Trials
Despite data from the bench that showed the device operated
in the manner anticipated, we wanted to undertake extensive
field testing. As discussed earlier, a device that is adequate for
a well-developed hospital may be inadequate for a developing
world setting.
A total of 114 units were constructed using volunteers coor-
dinated by a nonprofit corporation formed for the purpose of
manufacturing and distributing the BluLine: PhotoGenesis
Medical (www.photogenesismedical.com). These were di-
vided into three groups and shipped to hospitals in four countries.
The hospitals were chosen to range from small (approximately
20 beds) to very large (more than 500 beds) and from specialty
(maternity) to general and referral hospitals.
Every device was accompanied by two engineers. The engi-
neers attempted to install the device, train the staff to use the
device, and then interviewed the trained staff about the device.
For the first two groups, simulated clinical use was undertaken for
one month. Where simulated, clinical use includes at least occa-
sionally turning on the device and letting it run for several days.
Results
First Engineering-Field Trials
From the first build, 56 units were completed by 65–75 volunteers
(approximately 200 volunteers were turned away for this build
session). The cost for each unit for the first build was US$65.62.
This can be compared with a commercially sold unit whose retail
price can be several thousand dollars (Table 2). Each unit required
approximately five volunteer man-hours to complete. Despite
practice builds by the engineering team, eight procedures devel-
oped for the build requiredmodification during the build.
Thirty-nine of the 56 units were shipped to hospitals in Tan-
zania, Nicaragua, and Honduras. Of those shipped, 30 worked
upon arrival and 38 worked after minor engineering correc-
tions (Table 4).
No developing world installation complained about the lack
of a stand. Most hospitals hung the device from the ceiling, as
the cribs were typically not moved, and in any case completely
filled the available space to overflowing, including several
infants in each crib. A few hospitals preferred a drip stand to be
used for the device, and others constructed a stand for the
device, the available manual labor being relatively inexpensive.
Table 3. The most important design criteria and require-
ments for phototherapy identified from interviews conducted
in developing world hospitals.
Power requirements
Rechargeable >8 h on battery alone after full
charge
Charge while light is running
and line power is on
Battery lifespan Two years with daily outages
Battery availability in
country
Comparable to a 12-V car
battery or 6-V motorcycle
battery
Light source
Intensity 8–30 lW/cm2/nm
Wavelength 425–475 nm
Life time Bulb > 5 years normal use
Spot size 8 in2
User interface On/off button only
The needs for a rechargeable battery and a very long-
lasting bulb would not have appeared on a similar speci-
fication list for a U.S. hospital.
(a)
(b)
Fig. 1. (a) and (b) The design of the phototherapy device’s
illuminating head consists of three plastic layers (acrylic in
black, elastomer in gray) compressing and connecting 55
LEDs in parallel. The bolts, symbolized by the dashed lines,
hold the pieces together and also allow for easy field repairs
with minimal tools.
2 A Fuse D1 D2
D4D3R1
Branch 1
Branch 2
6 V dc
+ Branch 3
BlueRay
Unit
Fig. 2. Schematic showing the final power supply. The origi-
nal power supply used a 12-V source and commercially
available power handling but turned out to be excessively
sensitive to power-line fluctuation. The diodes allow for auto-
matic switching between the wall transformer (shown as a
current source) and the battery, when the power line fluctu-
ates or fails. The diodes also serve to drop the voltage to
the level required by the BlueRay unit.
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which made them reluctant to use the device even when the alternative was no therapy at 
all. One person asked about FDA or CE approval, and no one asked about clinical 
efficacy data. 
 A second round of testing incorporated a new custom power supply, improved 
aesthetics, and a reduced cost to $45 USD. Thirty-five units were tested in the same 
hospitals in Tanzania, Nicaragua, and Honduras. All the units worked well for the first 
month of use and there were no complaints from the staff about the device.  
 The third and final round was conducted entirely in Kenya. This time, previous 
shipping problems were corrected and all of the 28 units worked upon arrival. All the 
staff members eagerly accepted the device and were glad to use it because they had no 
other option for treating infantile jaundice.  
 This device is an excellent example for the potential of a university-designed 
project to be implemented internationally. The authors comment on the obstacles that 
exist for bring a device to market. For many products, the cost of design and 
implementation can be $10-20 million USD 14, a price that exceeds the market for many 
design ideas. Major companies are reluctant to create products that could not make a 
profit in the developing world. That leaves the non-traditional, university-based program 
to serve as crucibles of innovation that can partner with the power of the private sector to 
accomplish the task of medical device generation.  
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ANALYSIS 
 Each of these programs provides valuable insight into the planning and evaluation 
of a program to deploy a low-cost medical device in a low-resource setting. Table 1 in the 
Appendix shows the important elements that are utilized in the studies. One theme that 
was consistent throughout all four projects is that development does not exist in a vacuum, 
nor is it accomplished by the isolated efforts of passionate individuals. The above 
examples demonstrate that the most effective way to implement a new device in a low-
resource setting is to collaborate with multispecialty teams.  
PROGRAM ORGANIZATION 
 The cited studies had several similarities in design-team structure that helped to 
ensure success at every level of the program plan and evaluation. All of them were 
university-based, which allowed the teams to utilize student and volunteer labor that 
would significantly reduce the design and prototyping costs. Universities have more 
opportunity to work outside of the bounds of the commercial marketplace and to pursue 
projects that find their value in benefiting humanity rather than generating a profit. 
Having said this, three of the groups consulted with and found support from private non-
university organizations in later stages of product development. They make no comment 
about obtaining outside funding sources such as the National Institutes of Health (NIH) 
or the Bill and Melinda Gates Foundation (Gates Foundation). Only Owens and 
Simmons11 mention the use of microfinance as a proposed funding source in their 
discussion. It fit their project particularly well, but it is an option that deserves further 
exploration as I go forward with the program plan.  
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 It is also essential to see the patience displayed in these organizations as they 
remain faithful to their intentions in the face of design failure. Three of them reported 
device failures that required redesign and new implementation plans. This perspective 
would need to be built into the group purpose early on in the process so that hindrances 
do not oppose the mission, but instead help to refine it and make it more successful in the 
long run.  
DESIGN OBJECTIVES 
The design teams for these projects presented important design principles that will 
be beneficial for Project Tiger Breath. Owens and Simmons11 made local manufacturing 
a priority for cutting-costs. Other groups suggested purchasing components from India 
and China as a means of cutting costs, but direct manufacturing is an important concept 
that not only will reduce costs, but would also provide local jobs in a resource-poor area. 
Specific cautions would need to be taken by the group to ensure that manufactures were 
able to provide quality products without resorting to oppressive labor practices such as 
child labor and/or non-sustainable wages, but that is beyond the scope of this discussion.  
 Malkin and Anand14 addressed the importance of device aesthetics and how they 
effect the end-user receptivity. Hospital staff members in the implementation centers for 
the phototherapy program were reluctant to use a fully functional device because in their 
opinion it looked “homemade.” Being American, the design team had more of a 
“function-centered” approach and admittedly assumed that the hospital staff would be 
eager to embrace their device because they had no other option. 14 They failed to take into 
account the pride and respect that their target cultures had for their own work. The local 
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workers were offended, and in some manner insulted, by the assumption that they didn’t 
deserve professional appearing products.  
PROGRAM ELEMENTS 
Two programs 13, 14were able to collect pre-design data from their target regions 
about what health concerns they wanted to see addressed by new technology design. 
Another used their personal experience in the target area and generated their own solution 
to the common problem of disability transportation.11 For future projects, based on this 
review I would recommend that significant effort be given to collect pre-design data that 
identifies specific needs and supports the selection of the proposed project. Otherwise, 
you may run the risk of creating a product that is neither needed nor implementable.   
 The researchers were able to incorporate laboratory trials into their 
implementation plan as the first step to ensure safety and functionality. This step requires 
an addition phase to be planned as part of the program plan, but it would likely pay 
dividends by making the real implementation phase more successful.  Consistent with the 
theme of running trials, the teams also planned multi-phased implementation plans. This 
is important to assume from the outset because it allows a program to accept as “steps” 
what otherwise would be perceived as failures.  
 Another important implementation element that this review identified was the use 
of multi-site implementation as opposed to collecting data from only one site. This 
approach adds diversity and provides access to greater numbers of patients that can be a 
part of the evaluation. This facet of the plan could be completed regionally (e.g. multiple 
hospitals in northern India) or globally (e.g. India, Ghana, Honduras) with different 
evaluation plans in place for both schemes. 
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EVALUATION 
None of the studies focused a lot of attention on the evaluation steps of their 
design programs. This is likely because they were written for a predominantly 
engineering-based audience. Two programs did collect both qualitative and quantitative 
data that could be used to define success for the program implementation and guide the 
next round of design and implementation.12, 14 Interestingly, none of the programs 
reported pursuing federal approval for their medical devices. Likely only two programs 
would have had possible concerns for their devices. Malkin and Anand state, “We believe 
that very few, if any, medical-device manufacturers in the developed world would build a 
device for distribution in the developing world without FDA approval or a CE mark. 
Indeed, under section 802 of the FDA rules, manufactures of a medical device 
exclusively for export from the United States must still be able to obtain approval, 
although actually obtaining such approval is not required.”14 In their view, ignoring these 
regulatory bodies is an efficient way to reduce costs.  
 
CONCLUSION 
 Team-based device design and implementation is a vibrant way for (deleted 
Western) engineers to be involved in contributing to global health care disparities and 
fostering international collaboration. These four programs represent the extent of the 
published literature on low-cost device design for low-resource areas. It is likely that 
many more devices have been created and have never been published. The programs that 
were discussed provide general guidelines and a valuable framework for Project Tiger 
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Breath including being university-based, focusing on longevity, ensuring local relevance, 
and investigating the project results.  
 Based on the systematic review, it is evident that good program planning and 
evaluation are ingredients for a successful medical device program. The following 
sections will outline the program plan for Project Tiger Breath and discuss how each 
aspect of program planning and evaluation can be achieved collaboratively.  
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PROGRAM PLAN 
OVERVIEW 
 Project Tiger Breath is intended to develop a method for providing sustained, 
mechanized ventilation for newborn children in low-resource areas around the world. It is 
slightly different from most public health interventions because it begins with the 
development of a physical device that will then be used as part of a program to test and 
evaluate the device and effectively provide the device to areas where it is of greatest need. 
The success of Project Tiger Breath depends on the coordinated efforts of engineers, 
physicians, nurses, patient families, and researchers. The ultimate aim of Project Tiger 
Breath is to reduce infant mortality in low-resource areas by providing a therapeutic 
bridge for newborns that are experiencing respiratory distress.  
 The project was conceptualized while I was working in Duncan Hospital in Bihar, 
India. Because of this, it is likely that the initial focus of the project and the first round of 
clinical trials will be in India. Once the device is created and shown to be effective it will 
not be limited to only the Indian subcontinent.  
 Duncan Hospital is a 200-bed hospital located in Raxaul, India on the border of 
Nepal. It is the only secondary referral center run by the voluntary sector for 3 districts in 
North Bihar (6 million people) and Southern Nepal (5 million people). The service 
priorities of the hospital are Obstetrics and Gynecology, Medicine, Surgery, Pediatrics, 
Ophthalmology, Dentistry, and Radiology.  They average ~5000 deliveries a year and are 
staffed by 1 obstetrician and 2-3 junior medical officers. Newborns requiring intensive 
care are transferred to an intensive care unit (ICU) staffed by an anesthesiologist, 
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pediatrician, and internist, each of which trained a state-of-the-art medical institutions in 
the south of India.  
 Project Tiger Breath will be university-based, capitalizing on the potential of 
universities as centers for humanistic entrepreneurship with the freedom to innovate for 
the betterment of society. Their role will be to develop the ventilation device, the Tiger 
Breath Ventilation Assist Device (VAD). The program plan involves three phases: 
Development, Implementation, and Evaluation. Each of these phases will be discussed 
further in the following program plan. 
PROGRAM CONTEXT 
POLITICAL ENVIRONMENT 
 India is striving to make large leaps in public health in the current political 
environment. As globalization continues to advance, India is looking to solidify its 
position as a reputable country well on its way to successful development. The National 
Rural Health Mission, the government agency in charge of improving health for India, 
has been working aggressively since 2005 to address maternal and child health in 
particular along with communicable diseases, hospital quality, overall infrastructure, and 
the list goes on.15 Working to effectively provide improved care to children at low cost 
using resources that already exist in the health care system is likely to not face much 
political opposition.  
LOCAL, STATE, AND NATIONAL PRIORITIES 
 I believe that the hardest level to penetrate would be the local priorities. On a state 
level, Bihar is similar to the old Wild West. The rule of law and policy is often only a 
formality and bribery actually gets things done. Duncan Hospital operates within this 
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culture, striving to be above reproach and ethical, not being a part of the lawlessness in 
their state. State politics and barriers could be overcome, but there may be some 
opposition such as tariffs or fees.   
PROVIDERS AND RECIPIENTS 
 Locally, the staff at Duncan Hospital is composed of well-trained doctors working 
in a low-resource hospital. I would fear that there might be opposition to using a 
ventilator that did not look professionally made even if no ventilator is the other option. 
The device would have to be studied such that it can be proven beneficial and cost-
effective as well as manufactured using a professional casing and branding that add to the 
authenticity of the device.  It may be that simply introducing a new device that requires 
training, adaptation, and maintenance will be overwhelming to the ICU staff. As a 
primary testing center, Duncan Hospital would receive the devices free of charge, and 
Project Tiger Breath would be willing to provide the finances needed to conduct the 
project in Bihar.  
POSSIBLE FINANCIAL RESOURCES 
 US-based funding from the NIH and the Bill and Melinda Gates Foundation are 
possible sources for funding the development and prototype phases of implementation as 
well as the first year of testing and evaluation. Future expansion of the device is intended 
to be accomplished using sales and donations. The device is priced such that low-
resource hospitals or donors that are interested in serving a specific area could easily 
purchase it.  
TECHNICAL FEASIBILITY 
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 The device is designed to be easy to implement into current respiratory protocols. 
It accommodates ambu bags that are ubiquitous in most hospitals and has few moving 
parts. The device has well-labeled, easy to use knobs that control the breaths per minute. 
There are 9 labeled cams that can be used for 9 different combinations of volumes of are 
delivered at different speeds. The device comes with complete instruction manuals for its 
few moving parts. 
STAKEHOLDERS 
 Because Project Tiger Breath is being completed through collaboration there will 
be some need to balance the stakeholders in the project. The first design iteration for the 
Tiger Breath VAD has already been completed at Clemson University. At any given 
point the project remains my intellectual property as the primary program planner. 
Clemson University is not interested at this point in continuing the project. As an effort to 
thank them for their involvement, the device was named after Clemson’s mascot, and 
their involvement will be plainly noted on all materials. In the future, other universities 
such as UNC-Chapel Hill, Duke, or Wake Forest may collaborate as well. Prior to 
beginning any future relationships, proprietorship will be discussed. 
 Hospitals where the device is used will have a large stake in the success of Project 
Tiger Breath because it is their patients that will be directly affected. The management 
team for Project Tiger Breath will have to negotiate the impact the program 
implementation makes on local hospitals, state health departments, and governmental 
ministries of health. 
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GOALS AND OBJECTIVES 
GOAL 
To provide low cost effective mechanical ventilation to neonates in under-resourced areas 
around the world.  
 
OBJECTIVES 
SHORT TERM 
1. By the end of 2011 the project manager will have identified all components of the 
design team including university affiliates, medical advisors, international 
partners, collaborative companies, and private investors.  
 
2. By June 2012 the project manager and associated team members will have applied 
for and received sufficient funding for furtherance of the project. 
 
3. By the end of 2012 the design team will have a fully functional prototype that has 
passed laboratory testing and is ready to be implemented in target hospital(s). 
 
4. By the end of 2013 the initial trials will show that the TBVAD is safe and 
effective as a ventilation device. 
 
5. By the end of 2013, the evaluation team will show that PTB has been 
implemented in a culturally relevant and beneficial way for the hospitals in which 
it operates. 
 
6. By the end of 2013, PTB will continue to function in an organized, cost-effective 
way that is making progress towards the appropriate goals. 
 
LONG TERM 
7. By the end of 2014 the development team will have distributed the Tiger Breath 
VAD to at least 50 hospitals 
 
8. By the end of 2015 the development team will have distributed Tiger Breath VAD 
to at least 150 total hospitals  
 
9. By the end of 2015 completed trials that show a 20% reduction in respiratory-
related neonatal morality   
 
10. By the end of 2016 the development team will reconsider whether the prototype 
design needs to be readdressed and updated with better technology. 
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PROGRAM THEORY 
PROGRAM THEORY 
 The goal of a program theory is to explain how a specified program will address 
an identified health problem. 16 The “diffusion of innovation”17 theoretical model is 
designed to allow public health practitioners to use their resources must efficiently for 
“the reach, adoption, implementation, and maintenance of programs. ”17  At the base of 
this theory is the belief that innovation spreads through a society, rather than being 
planted as a typical program might.  It takes into account the reality that for an innovation 
to be successful it must be accepted within a social system in a timely manner; first by 
innovators and early adopters and ultimately reaching the late adopters and laggards in 
the group. 
 The main attributes of the theory are as follows: relative advantage, compatibility, 
complexity, trialability, and observability. 17    I will discuss each of these below. 
DIFFUSION OF INNOVATION THEORETICAL MODEL 
 
 Implementing the Tiger Breath VAD will involve developing the device, 
conducting laboratory testing, designing proof-of-concept studies, implementing the 
device in hospital protocols, and evaluating the performance. For much of the developing 
world, there is a disconnect between the technology that is available in modern hospitals 
and the reality that exists in local wards. It is hoped that this device, being low-cost, 
simple in design, and similar to current methods will help to bridge the gap as hospitals 
work on modernizing their intensive care systems.  
 The plan to implement Tiger Breath will be rooted in the “diffusion of 
innovation” theory.17 This theory examines how new ideas overcome their novelty in 
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order to be spread to become a part of what a society perceives as normal. It 
accomplishes this based on the following concepts: 
INNOVATION 
 The Tiger Breath VAD is a simple device that is meant to make a small and 
incremental change that improves the outcomes for children and families that require 
mechanical ventilation in areas where no ventilators exist. This product will be perceived 
as unique by some institutions simply because it will be an obvious intervention where 
there had not previously been one. It will create a new barrier of mechanization that will 
need to be understood by staffs and families at a pivotal point in a new child’s life.  
COMMUNICATION CHANNELS 
 Information about Project Tiger Breath will be transmitted through a variety of 
channels. Initially, testing and primary implementation will take place through 
connections that are established with the design team. Following testing and proof-of-
concept evaluation phases, the performance of the Tiger Breath VAD would need to 
provide specific communications that will demonstrate the value of the product. These 
communications will need to reach doctors working in the far reaches of low-resource 
areas, so creativity will be required.   
SOCIAL SYSTEM 
  The innovation would need to be adopted by physicians and nurses in rural 
hospitals. Several barriers are likely to impede full adoption. A similar device, discussed 
in the Systematic Review14 was slowly received by staff at the testing hospital because 
they feared it looked “homemade.” Despite having proven efficacy and being well-
adapted for their conditions, the device still had to be accepted as legitimate for use on 
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humans. Many providers that work in rural hospitals around the world trained in 
university medical centers and would be reluctant to accept a device that deviated from 
the quality they would expect from a medical device. This will be an objective for the 
design partners and a final design plan will not be accepted without addressing it. 
TIME 
 Adopting the Tiger Breath VAD could happen quickly. The device is budgeted to 
be produced in an initial order of 1,000 so availability would not be an issue. 
Incorporating the device into hospital protocols would be smooth, especially since the 
protocol would have previously included “teach the parents to control bag compression.”  
 Ultimately, the time required to diffuse an innovation will be dictated by the 
effectiveness of the design. The Diffusion of Innovation theory provides a framework for 
estimating this by defining the key attributes that will determine the rate of diffusion.  
RELATIVE ADVANTAGE 
 A new design is only an innovation if it improves the process it is intended for. 
Tiger Breath is designed to be implemented only in places where mechanical ventilation 
is not available. If it is proven to operate safely without introducing any hazard to 
children, it will be likely to be better than having no intervention at all. The studies 
accomplished in the evaluation will confirm this improvement for hospitals that adopt it. 
COMPATIBILITY 
 The Tiger Breath VAD is designed to work easily in a low-resource environment. 
It is capable of functioning at a range of voltages (up to 220 V found internationally). The 
Tiger Breath VAD will utilize a battery back-up power system that has a battery that is 
charged using electricity coming from the grid that is wired in parallel and able to 
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provide power seamless in the event of rolling power outages. The material is easy to 
sterilize and has interchangeable parts that can be used while others are being cleaned. 
The Tiger Breath VAD was designed with compatibility in mind. It can be adjusted to 
accommodate any style of ambu bag and keeps the moving parts microbiologically 
isolated from the airway. 
COMPLEXITY 
 Incorporating a set of only nine different cams, the Tiger Breath VAD can easily 
be adjusted and used for a variety of neonate sizes and breath rates. With the turn of a 
dial and switching of a plastic piece the device can easily work on any given neonate.  
TRIALABILITY 
 The innovation will not be easy to try without adopting, simply because of 
shipping costs. The device can be tried for a short period of time without much of an 
investment and could be returned if facilities are not satisfied with the device. The 
advertising of Tiger Breath would include online demonstrations and a full description so 
that hospitals could be fully informed of their investment prior to purchasing. 
OBSERVABILITY 
 The impact of Project Tiger Breath will be simultaneously subtle and apparent. 
Children that use the machine will likely recover at better rates than they do using only 
manual ventilation, and that would be encouraging and obvious. In addition to the clinical 
outcomes seen in the newborns, the Tiger Breath VAD is likely to alleviate much of the 
psychological and physical stress that parents experience when they bear the 
responsibility of providing ventilation to their newborn. These effects will likely be large 
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and valuable and will therefore be studied in the pre- and post-implementation phases so 
that an improvement can be tracked.  
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IMPLEMENTATION PLAN 
 Project Tiger Breath is a multidisciplinary effort to provide a mechanical device 
that supplies ventilation for newborns in low-resource areas. In order to do this, it is 
necessary to ensure that a few essential elements are covered. The program’s goal is to 
ultimately reduce neonatal mortality due to respiratory distress by 20% in the serviced 
regions within 3 years of the beginning of clinical trials. Along the way, other 
intermediate goals and requirements will be addressed by the program’s activities. The 
important program activities include device design, clinical trial organization, and 
product diffusion. Each of these activities will be judged based on core requirements of 
effectiveness, relevance, and sustainability.  
 DEVICE DESIGN 
 Universities will serve as the incubators for Project Tiger Breath. As seen in the 
systematic review, the resources and missions of universities enable them to provide 
multidisciplinary design teams often at little to no cost. By partnering with universities, 
Project Tiger Breath will accomplish two different purposes. At first glance it seems like 
the only purpose for partnering with training institutions is to have access to cheap labor, 
but that focus is too limited in scope. Partnering with students invites them to reconsider 
their plans for the future and teaches them that their skills are applicable and needed for 
helping to improve the conditions of people all over the world. This adds to the 
sustainability not only of Project Tiger Breath, but also of new projects that have yet to 
be created. Providing globally focused design projects whether as class credit or 
volunteer activities helps students to develop a more thorough and diverse view of their 
potential in their chosen career path. Achieving this objective ought to be desirable for 
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universities leading them to be interested in a partnership.  
 University teams will be composed primarily of engineering students from either 
biomedical, electrical, or mechanical engineering as well as other students from disciples 
like business, advertising, graphic design, packaging science, etc. They will be led by the 
project manager and appropriate faculty members. Their responsibility will be to design 
and optimize the device using the tools and resources at their disposal.  
 The first design iteration for Project Tiger Breath has already taken place at 
Clemson University where in the fall of 2010 approximately 25 senior engineering 
students collaborated as 5 teams to design the first prototype. The students completed this 
project as part of one of their required design courses. The process required the project 
manager to prepare a lecture providing the vision for the project, the background 
information, basic physiology, and design parameters. After that initial meeting, the 
project manager corresponded with the teams on a weekly basis as they had questions and 
developed their design. For Clemson, this project did not require additional resources 
because the students were required to complete some type of design project already. This 
process will be repeated in future iterations of the product design.  
 The first objective, scheduled for the end of 2011, is to identify all of the 
components of the design team, including the university affiliates. The possibilities for 
partnership include three programs: Clemson University, either with the mechanical 
engineering department or an Engineers Without Borders chapter; UNC Chapel Hill, in 
collaboration with the Gillings School of Global Public Health’s Innovation Lab; or 
Wake Forest University where the project manager will be continuing his training. Once 
the partnership is formed, the university affiliate will be responsible for completing the 
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final, fully functional prototype by the end of 2012.   
CLINICAL TRIALS 
 Beginning in 2012, Project Tiger Breath will move into the clinical trial phase. 
According to Objective 1, the project manager will identify international hospitals that 
are ready and willing to conduct clinical trials of the device in 2011. The first trials will 
take place at only one hospital and will be effectiveness trials not superiority trials, with 
the aim of supporting that the device can be safely implemented. They will be conducted 
by medical students that have been recruited from either UNC Chapel Hill or Wake 
Forest Bowman Gray and by local physicians that are personally invested in the project. 
One or two engineering students will accompany the device to its destination to help with 
the first few weeks of training the local staff to use the device. The outcomes of these 
trials will be short-term neonatal outcomes including pulse oximetry readings, blood pH, 
and discharge from the hospital. Based off of the information collected in the trails, 
appropriate changes will be made to the device. 
 The first clinical trial will also test the program’s relevance in the low-resource 
hospital setting. Although extensive predesign data collection will have been done to 
guide the team, the first clinical trial will confirm their findings. This phase will teach the 
program planning team about the obstacles that will be prevalent as hospitals begin to 
incorporate the Tiger Breath VAD into their hospital protocols. It may be that despite the 
best intentions of the engineers and planning teams there is a risk that the project will not 
be relevant. Incorporating international partners early in the process as a part of objective 
1 in 2011, prior to the trials in 2012 is the best way to minimize this risk and insure 
project sustainability.  
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PRODUCT DIFFUSION 
 Once the efficacy trial is complete, the design team will incorporate any changes 
that were deemed necessary following the trial.. At this point, Project Tiger Breath will 
move into its third phase—product diffusion. Distributing the project will require more 
input from volunteer and like-minded organizations. The first long-term objective is to 
have the Tiger Breath VAD distributed to 50 hospitals by 2014. In order for this to 
happen hospitals, donors, travelling volunteers, and hospital suppliers need to know that 
it is available.  
 By the end of 2013, we anticipate having published the findings from the efficacy 
trial in a global health journal. This will provide a form of advertising to potential 
physicians that may be interested in purchasing a few products. These physicians may 
also be willing to help be a part of a long-term trial that can be used to evaluate the 
success of Project Tiger Breath. Unfortunately, the vast majority of the physicians that 
could use the Tiger Breath VAD would not have access to journal articles, nor have the 
time to read them every month.  
 Project Tiger Breath will have to be more creative and use other avenues for 
distribution. The most likely source will be to tie into other existing channels for 
distributing medical devices that other companies use in India, for instance. There is no 
reason to recreate an infrastructure that already exists. The Tiger Breath VAD should be 
sold to medical device companies as a product they can then represent and disperse as 
they would any other device.  
 American volunteers would likely also serve as an avenue for distribution. The 
device was designed originally to fit into a suitcase that could be carried to a low-
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resource hospital by a visiting volunteer and left as a donation to the hospital. Potential 
volunteers would find out about Project Tiger Breath through electronic resources such as 
a website, Twitter feed, and online advertisements. The largest barriers to distribution are 
ultimately the sustainability of the product and its short-term effectiveness. The 
ventilation device is budgeted to cost less than $100 USD, but even that seemingly small 
of an investment, without significant results the program will never be successful.  
RESOURCES 
 During the first phase of product design, the program will require minimal 
resources thanks to the partnership with universities. If funding is secured in time, it 
would be ideal to be able to provide ~$1000 to help support the design teams to make 
multiple prototypes and conduct safety testing. The second phase, which involves travel 
for at least 4 people, will be the first major expense. Travel expenses will depend on the 
funding source, but ideally there will be $10,000 set aside to at least assist the 4 students 
with the 1-2 months abroad. Once it is time to begin advertising and distributing the Tiger 
Breath VAD the costs will increase substantially. Depending on the source used, 1 year 
of advertising would cost ~$2000/month, or ~$24,000. This is yet another reason why 
Project Tiger Breath should focus on using existing medical device sales companies to 
disperse the Tiger Breath VAD.  
FUNDING 
 Project Tiger Breath is designed to be sustainable once it has reached a critical 
distribution, but until that point outside funding will be necessary to sustain the program. 
Because infant mortality is such an important metric for improving health around the 
world, several funding organizations are likely to support efforts like Project Tiger Breath. 
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Objective 2 indicates that by June 2012 the program team will have applied for and 
received funding that will carry the program through 2016. Currently, the NIH and Bill 
and Melinda Gates Foundation as well as other smaller foundations prioritize sustainable 
innovation for addressing the Millennium Development Goals. Other organizations such 
as the Program for Appropriate Technology in Health (PATH) are potential partners that 
would be able to provide capital for making the project sustainable early on.  
SUSTAINABILITY 
 The best way to ensure sustainability is to design the best product possible that 
works well, is reliable in variable conditions, and has parts readily available. A recent 
study of broken medical devices in the developing world showed that the most common 
causes of machines not working were power supply, user error, and lack of spare parts.18 
The Tiger Breath VAD is designed to work on a variety of power supplies and can be 
battery operated at any time that power is not available. It is purposely simple to use and 
is designed using common parts that are more likely to be available overseas.  
 Overall program sustainability will depend on funding of the program, 
communication between the partnering organizations, and a commitment to excellence. 
These elements will be covered more thoroughly in the Evaluation section of this 
discussion. Ultimately, the program will transition into mostly a manufacturing and 
distribution program that will be sustained through individuals purchasing the product 
and using it in their hospitals.  
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EVALUATION PLAN 
 
RATIONALE FOR EVALUATION 
 In her book Applying Quality Management in Healthcare, Diane Kelly states, 
“Conducting an activity is not the same as achieving the results intended by that 
activity.”19 Because this reality is possible, evaluation is a necessary part of the life of a 
program. In this discussion I will address why an evaluation is necessary for Project 
Tiger Breath as well as begin to answer a few questions about the evaluation process that 
are important to discuss at the outset. 
 Each program will have its own purposes for performing an evaluation. Some 
parts of an evaluation will be quantitative and goal-oriented. These focus on whether or 
not the program is producing the desired outcomes and is on track to meet its goals. Other 
parts will be more qualitative and process-oriented. These parts are concerned with how 
the outcomes are being obtained and provide information that goes deeper than numerical 
outcomes. Additionally, because of increasing attention to fiscal accountability in the 
current funding culture, a program needs to be judged based on its efficiency and cost-
effectiveness. These aspects of an evaluation focus on how resources are utilized so that 
supporters can be confident that their money is being properly appropriated. Ultimately, 
the purpose of an evaluation is to give structure to the process of continuous quality 
improvement so that a program can reach its goals as effectively as possible.  
 For an evaluator of Project Tiger Breath, the role would be three-fold: The project 
must prove to be safe and medically effective; it must be implemented in a culturally 
relevant and sustainable way; and it must be progressing towards its goals in a timely 
fashion. The evaluator will be an important bridge between the high-resource, university 
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teams and the low-resource, clinical teams that will provide opportunities for objective 
communication. For Project Tiger Breath, I would recommend that we begin with an 
internal evaluation, possibly from an experienced board member, during the first 2 years 
while the project is still in the trial phase. Once the project is in the distribution phase and 
becomes more sustainable, Project Tiger Breath should budget for and hire an external 
evaluator that helps to monitor the process from manufacturing to use in a hospital setting. 
 The stakeholders for Project Tiger Breath include the engineering design team, 
physician consultants, in-country medical practitioners, and project funders, as well as the 
patients and their families and the population of the communities in which Project Tiger 
Breath is implemented. The engineering design team will need to have questions about 
the safety of the device answered and will want to know areas where it can be improved. 
Physician consultants will be interested in the outcomes for the children that are using the 
Tiger Breath Ventilation Assist Device (VAD). In-country practitioners, patients, and 
communities will want to know that the devices is being used in a way that is beneficial 
for them, and in a way that is sustainable and profitable for their hospital and community. 
Finally, the financial stakeholders will want to see that the project is meeting its goals 
with respect to outcomes and distribution on schedule.  
 The evaluation will surely face difficulty. The most obvious one is that it will 
definitely cross countries, and probably function on 4-5 continents. This is why I feel that 
having an internal auditor that is already comfortable with the idea of crossing cultures 
and travelling abroad will be helpful for the project. The evaluation will also wrestle with 
the tension of having to deal with the reality for hospitals that operate in low-resource 
settings. The evaluation and recommendations will have to be made with a strict 
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adherence to cost-effectiveness and may need to concede some elements of quality for 
the sake of sustainability. These challenges will not be easy, but processing through them 
will ultimately make Project Tiger Breath a better and more successful program. 
! %"!
EVALUATION STUDY DESIGN 
 The evaluation for Project Tiger Breath will focus on three basic questions that 
will be used to judge the success or failure of the project in the short-term: 
1. Is the Tiger Breath VAD safe and effective? 
2. Is project being implemented in a sustainable way that is culturally relevant and 
beneficial for the hospitals in which it operates? 
3. Do all the stakeholders feel that the project working in an organized, cost-
effective way towards the appropriate goals? 
The first evaluation question is outcome-oriented and will be addressed in a quasi-
experimental. The last two questions are process-oriented and will be addressed using 
qualitative methods that are more observational in nature. 
OUTCOMES EVALUATION 
 The primary goal of Project Tiger Breath is to reduce infant mortality in the 
communities that are supplied with the Tiger Breath VAD. This goal will have short-term, 
individual outcomes as well as long-term population outcomes. Evaluation question #1 is 
concerned with the individual outcomes that will serve as intermediate outcomes that will 
point toward the long-term goal of reducing neonatal mortality. Measuring outcomes in a 
controlled, hospital environment is easier than some other settings that public health 
programs function within, but it is not without difficulty. Serious attention will need to be 
given to ensure that data collection is done in a rigorous fashion. 
 Question 1 will be addressed using a two-group, prospective quasi-experimental 
cohort study. Project Tiger Breath plans to have a functional prototype ready for 
evaluation at the beginning of 2012, however it will have the three partner hospitals 
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identified by the end of 2011. During 2011, the children that experience respiratory 
distress syndrome will be used as the unexposed cohort. These children will receive the 
standard of care in their hospital at the time, either intermittent manual positive pressure 
ventilation or no ventilation, and their outcomes will be tracked. Throughout 2012, basic 
records will be collected about the births that take place in the hospital so that the 
outcomes for children can be reported with per 1000 live-births as a denominator. After 
2012, once the Tiger Breath VAD has been delivered and the teams have been trained, 
the international partners will collect data on the outcomes for all the children born in the 
hospital that experience respiratory distress syndrome and require ventilation. For the 
moment, children that are not born inside the hospital will not be included in the study. 
While this obviously fails to include a large percentage of most rural populations, there is 
not a way to ensure that treatment could be equal between the two groups.  
IMPLEMENTATION EVALUATION 
 The second and third evaluation questions address the implementation of Project 
Tiger Breath. They will be observational studies that use qualitative measurements.   
Question 2 is primarily concerned with how the project is being implemented in the low-
resource hospitals. As a matter of definition, this question assumes that a program that is 
being implemented in a context-appropriate way that improves the workplace for 
international workers is sustainable. The evaluation will be an outcome documentation 
that is pre-experimental and will collect data from one group (i.e. hospital employees) 
after the intervention has taken place. These data will then be analyzed and used to 
improve the Project Tiger Breath implementation process. The motivation for this 
question come from the results found in the systematic review from Malkin et al that 
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indicate hospital staff not accepting a device as a valid medical device because of its 
ruggedness can be a cultural insult and a barrier to the success of the program.  
 The third question will be a similar design, but will focus more on the activities 
that are taking place in the United States for Project Tiger Breath. This process will be an 
observational study that documents the outcomes of the program after the first 1-2 year 
interval. The evaluation will gather information about the budget for Project Tiger Breath 
compare that to money actually spent. It will also focus on making sure that all of the 
stakeholders are on the same page with the mission and vision of the project as well as 
their role in it.  
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EVALUATION METHODS 
 The evaluation for Project Tiger Breath will use several different methods to 
measure the success of the program. The use of the methods will be somewhat different 
for each of the three evaluation questions, so they will be dealt with individually. 
 The first question, which focuses on outcomes, will collect data quantitatively. 
The information will come from a data registry that is collected prospectively for each of 
the cohorts of patients. The variables of interest will include maternal demographics, 
maternal complications, delivery method, delivery complications, birth weight, gender, 
diagnosis, intrapartum complications, APGARs, time from delivery to recognition of 
symptoms, time from symptoms to ventilation, duration of ventilation and settings used, 
neurological function, as well as diagnosis and any laboratory findings. The primary 
outcome for the study will be discharge from the hospital. Secondary outcomes will 
include length of time on ventilator, recorded acidosis/alkalosis, and neurological 
function of the infant at discharge. Data will be collected with respect to each of these 
variables and will be used in a statistical analysis.  
 The second question will be addressed qualitatively, deriving most of its 
information from focus groups and key informant interviews. After the training and 
implementation the evaluator will conduct focus group discussions with the hospital staff 
to gather input about their experience of the training and the implementation. The training 
and implementation will be viewed as two separate events needing to be evaluated, not a 
time course pre/post-test data collection. The hospital physicians and nurse managers will 
be interviewed as key informants using a structured interview asking specific questions 
about the cultural appropriateness of the program. Using these data, the evaluation team 
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will be able to make suggestions to the Project Tiger Breath board about the 
implementation of the program. 
 The third question will use online digital surveys, documentation review, and 
structured interviews to collect its data. Each of the stakeholders will be sent an online 
survey that asks them to rate their experience and understanding of the program’s mission 
and vision. These surveys will include free response sections that will allow them to state 
in their terms their role within the project as well as to explain the mission of the project 
as they see it. At this point in the evaluation, the evaluator will also review the budget of 
Project Tiger Breath as well as the actual expenditures and will examine where the 
money is being spent and make a judgment call  (based on the specified goals) whether 
the program is meetings its goals in a cost-effective manner. If specific issues are raised 
in the online surveys or in the budget analysis, the stakeholders of interest will be 
personally interviewed in order to gain as much information about possible shortfalls in 
Project Tiger Breath.  
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EVALUATION TABLES 
 
Short-Term  
Objective 4 
By the end of 2013 the initial trials will show that the TBVAD is safe and 
effective as a ventilation device. 
Evaluation Question Participant  Evaluation Method 
Did Project Tiger Breath complete the 
initial trials by the end of 2013? 
Project manager Review of records 
Publication manuscript 
Did the trials show that Tiger Breath 
VAD was a safe device? 
Project manager 
International 
partners 
Statistical analysis 
Publication manuscript 
Did the trials show that Tiger Breath 
VAD is an effective device? 
Project manager 
International 
partners 
Statistical analysis 
Publication manuscript 
Were the trials run as planned whereby 
they reduced biases to the fullest extent 
possible? 
Project manager 
International 
partners 
Review of records 
Structured interviews for 
clarification 
Were there any issues with the data 
collection and/or analysis that would 
invalidate the study? 
Project manager 
International 
partners 
Review of records 
Structured interviews for 
clarification 
Do the results of the study provide 
enough information to allow Project 
Tiger Breath to move forward? 
Project manager 
International 
partners 
Review of records 
Structured interviews for 
clarification 
Were any weaknesses identified in the 
trial that could be used to improve the 
process in future iterations? 
Project manager 
International 
partners 
Publication manuscript 
Structured interviews 
 
 
Short-Term  
Objective 5 
By the end of 2013, the evaluation team will show that PTB has been 
implemented in a culturally relevant and beneficial way for the hospitals 
in which it operates.  
Evaluation Question Participant  Evaluation Method 
Was Project Tiger Breath implemented 
in the target hospitals? 
International 
partners 
Structured interviews 
What was the reaction of the staff to the 
training program for Project Tiger 
Breath? 
International 
Partners 
Focus Group Discussions 
Did conducting the training and the 
clinical trial increase the staff’s 
knowledge about the management of 
acute newborns? 
International 
partners 
Focus Group Discussion 
Did the training and involvement in the 
clinical trial ultimately change the 
behavior of the staff in a positive 
direction? 
International 
partners 
Focus Group Discussion 
How did the staff feel about being a 
part of the trial? 
International 
partners 
Focus Group Discussion 
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How did the staff feel about the quality 
of the device? 
International 
partners 
Focus Group Discussion 
Does the staff feel that the arrival of the 
Tiger Breath VAD and its 
implementation into their practice has 
been a positive experience for them, 
their hospital, and patients? 
International 
partners 
Focus Group Discussion 
Were there any aspects of the 
implementation plan that could be 
changed in order to improve the 
international operation of Project Tiger 
Breath? 
International 
partners 
Focus Group Discussion 
Structured Interviews 
 
 
Short-Term  
Objective 6 
By the end of 2013, PTB will continue to function in an organized, cost-
effective way that is making progress towards the appropriate goals. 
Evaluation Question Participant  Evaluation Method 
Is Project Tiger Breath functioning as 
an organized cooperation? 
Project manager 
Advertising 
partner 
Manufacturing 
partner 
Shipping and 
processing 
partner 
International 
partner 
Document review 
Online-survey with 
analyzed free responses 
Structured interviews 
Is Project Tiger Breath function in a 
cost-effective way? 
Project manager Review of documentation 
Do all of the partners feel that they are 
well informed about the about the 
vision and direction of the project? 
Project manager 
Advertising 
partner 
Manufacturing 
partner 
Shipping and 
processing 
partner 
International 
partner 
Document review 
Online-survey with 
analyzed free responses 
Structured interviews 
Did Project Tiger Breath stick to its 
budget in the first two years of 
operation? 
Project manager Document review 
What areas need to be readdressed so 
that resources can be used most 
effectively? 
Project manager Document review 
Are there any areas where the Project manager Online-survey with 
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communication and involvement 
amongst partners needs to be changed? 
Advertising 
partner 
Manufacturing 
partner 
Shipping and 
processing 
partner 
International 
partner 
analyzed free responses 
Structured interviews 
 
 
Long-Term  
Objective 1 
By the end of 2014 the development team will have distributed the Tiger 
Breath VAD to at least 50 hospitals in low-resource countries. 
Evaluation Question Participant  Evaluation Method 
Did Project Tiger Breath 
distribute VADs to at least 
50 hospitals? 
Project manager Document review (orders) 
What is the average number 
of units sold per hospital? 
Project manager Document review (orders) 
Have there been any 
difficulties operating the 
device that were not 
anticipated in the design? 
Project manager 
 
Structured interview 
How do the hospitals use 
the device, how often and 
for what conditions? 
Partner hospitals Document reviews (charts) 
Do the hospitals feel like 
the Tiger Breath VAD was 
a good investment that has 
improved their outcomes? 
Partner hospitals Structured interview 
Are there changes to the 
way the Tiger Breath VAD 
is designed, distributed, or 
implemented that need to be 
made? 
Partner hospitals Structured interview 
 
Long-Term  
Objective 2 
By the end of 2015 the development team will have distributed Tiger 
Breath VAD to at least 150 total hospitals in low-resource areas. 
Evaluation Question Participant  Evaluation Method 
Did Project Tiger Breath 
distribute VADs to at least 
510 hospitals? 
Project manager Document review (orders) 
What is the average number 
of units sold per hospital? 
Project manager Document review (orders) 
Have there been any 
difficulties operating the 
Project manager 
 
Structured interviews 
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device that were not 
anticipated in the design? 
Has Project Tiger Breath 
adapted to be able to reach 
this large number of 
hospitals? 
Project manager Review of budget structure, 
database 
Open-ended discussion 
Are there changes that need 
to be made to the leadership 
structure, information 
management, or other 
elements that will ensure 
Project Tiger Breath’s 
success and future growth? 
Project manager, all 
development partners 
Video conference 
discussion 
 
Long-Term  
Objective 3 
By the end of 2015 completed trials that show a 20% reduction in 
respiratory-related neonatal morality. 
Evaluation Question Participant  Evaluation Method 
Did the long-term trials in 
the 3-5 trial hospitals show 
a 20% reduction in 
mortality due to respiratory-
related illnesses? 
International partners 
Project manager 
Trial coordinator 
Review report 
What was the effect on 
mortality? 
International partners 
Project manager 
Trial coordinator 
Review report 
Are there easily identifiable 
factors that make these 
results seem reasonable? 
International partners 
Project manager 
Trial coordinator 
Structured interview 
Are there more elusive 
reasons that need to be 
considered that led to the 
results found? 
International partners 
Project manager 
Trial coordinator 
Structured interview 
What intangible changes 
have resulted from the 
implementation of Project 
Tiger Breath in the families, 
staff, and communities 
affected by the project? 
International partners 
Project manager 
Trial coordinator 
Open-ended discussion 
How can Project Tiger 
Breath use this long term 
data to improve the use of 
the Tiger Breath VAD and 
disseminated it more 
broadly around the world? 
International partners 
Project manager 
Trial coordinator 
Open-ended discussion 
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DISSEMINATION PLAN 
 Project Tiger Breath will communicate the results of evaluations continuously 
throughout the course of the program. The first round of evaluation will be disseminated 
in 2014 summarizing the program performance through 2013 after the short-term 
objectives have been accomplished. The results will first be distributed to the project 
manager and the heads of each partnering organization that are a part of the project 
through a written report and a summary video that presents the results visually so that all 
of the stakeholders can get a better sense of what the other is doing.  
 After the heads of each facet have had the opportunity to review the results, 
individual aspects will be discussed further with the teams that make up each of the 
program’s partnering organizations so that they can gain specific information about how 
their team can improve the overall program.  
 The program manager and evaluator will also seek to publish the results of the 
evaluation in a peer-reviewed scientific journal. The journal ideally will be an 
international journal with a wide distribution in developing countries that is also archived 
in PubMed so that interested researchers can easily locate the electronic version. The 
journal would need to appeal to an audience interested in pediatrics as well as medical 
technology. This method of dissemination should give potential purchasers awareness of 
the Tiger Breath VAD and provide them with some indication that it would work in their 
practice. 
 Future evaluations that address the long-term goals and objectives will follow a 
similar distribution plan. At each point in the life of the program greater emphasis will 
need to be given to different program partners. In the short-term phase, the program will 
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rely heavily on the design, clinical, and international partners while in the long-term 
phase there will be more focus on manufacturing and distribution. It is important to 
notice this transition in the life of the program, but it does not mean that there will be a 
time where one group’s skills are not required e.g. early prototype production will require 
communication with manufacturing partners, etc. 
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DISCUSSION 
 Developing medical devices that are low cost, easily maintainable, and medically 
effective is an important part of improving the health of people in low-resource areas.18 
Project Tiger Breath shows how the idea of one individual, combined with diverse 
partnerships, can lead to improvements in health for a number of people. It comes on the 
heels of a movement at the University of North Carolina at Chapel Hill that sees 
universities as a source for innovation that can make a real impact on the world.20 
 Project Tiger Breath is rooted in a solid program planning methodology that 
should help to sustain it through the years of actual implementation. The skills learned as 
part of designing the program can also be rapidly applied to future programs as well. 
Developing the program plan gave me the opportunity to clearly outline the background, 
reasoning, goals, activities, and evaluation of the project so that the necessary partners 
can be properly informed about the program from the outset. While the literature review 
was helpful, I believe that I learned as much from meeting with experts in the field of 
design and business and learning more about the resources available within the university. 
 I became more convinced that projects of this nature are best accomplished using 
a university-private partnership. Holden Thorp, the Chancellor of the University of North 
Carolina at Chapel Hill, along with Buck Goldstein endorsed this concept in their book 
Engines of Innovation: The Entrepreneurial University in the Twentieth Century20 In 
their minds, universities need to carry their innovative thoughts through into real tangible 
translation, not just theoretical forms of translation. At the same time, business can open 
up new and creative market places in conjunction with the innovation streaming from 
universities. Relevant to Project Tiger Breath, the popular medical device company 
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General Electric (GE) has begun to enter the market of low-resource medical devices 
ashamedly acknowledge they intend to make a profit. Forays like this are only possible 
with the partnership of years of university-based research in epidemiology, public health, 
and medicine. Companies like GE are in the perfect position to partner with large 
university initiatives, multilateral funders, and international partners to lead new 
advances in medical technology. 
My research into this topic has also shown me that Project Tiger Breath would be 
a small partner in a larger network of globally-minded design engineers. Engineering 
World Health (EWH) 21 is one such organization that comprises over 2000 engineers 
from six countries that is focused on developing creative solutions to some of the world’s 
most prevalent problems.9 In the future, Project Tiger Breath could learn from their 
methodology if new ideas are pursued as separate programs.  
 Unlike Project Tiger Breath’s inception as an idea that immediately sought a 
prototype, EWH encourages engineers to create prototype only for what the call “Projects 
that Matter” ranging from new blood pressure measuring devices to neonatal 
incubators.21 They also discourage prototype development until a manufacturer has been 
identified that can guarantee a feasible manufacturing plan.21 Without this, too many 
well-intentioned products get lost in the pipeline of development and never make it too 
the market.10 More than 95% of medical devices that are used in public hospitals in low-
resource settings are imported, predominantly from China.18 Learning  this fact helped to 
shape Project Tiger Breath by making identifying a manufacturing partner a short-term 
objective that should come before prototype completion. 
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 One long-term goal of Project Tiger Breath that cannot be understated is the 
desire to inspire new generations of globally-minded engineers. This intention is 
illustrated in the logic model found in the Appendix as Figure 1A. EWH along with other 
organizations have been able to accomplish this well. Ideally, the all results of Project 
Tiger Breath will not be easily measured in the evaluation. Some of them will come in 
the hearts of twenty-year-old men and women that travel with the devices to see the 
developing world for the first time. They will be seen in the jobs they choose, whether or 
not the pursue further education, and what projects they pursue in the future. There will 
probably not be a large enough cohort from the 2-3 design iterations at the partner 
universities to organize a study, but one possible future avenue of evaluation would to try 
and contact students affected by Project Tiger Breath and similar organizations to see 
what impact it made on their lives twenty years down the road. 
 Being grounded in the foundation of program theory and using rigorous 
programming and evaluation tools, Project Tiger Breath has potential to succeed through 
to implementation and effectual change. It will be a cross-cultural and transconteniental 
example of the human network working together to improve the lives of some of our 
most valuable members, children. 
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APPENDIX 
Table 1. Review of Studies Discussed in the Systematic Review  
(!: Not present ": Present) 
 
 
 Trait The 
Skeeter 
Recycled 
Incubators 
Hand 
Scale 
PhotoTx 
Pr
oj
ec
t 
O
rg
an
iz
at
io
n 
University-based organization " " " " 
Advocated team leadership structure ! ! " " 
External funding source ! ! ! ! 
Long-term plan " ! " " 
Partnership with non-university 
group " ! " " 
Consider microfinance as funding  " ! ! ! 
D
es
ig
n 
O
bj
ec
tiv
es
 
Low-cost (<10% of commercial cost) " ! " " 
Manufactured in target country " ! ! ! 
Locally repairable " " ! " 
Improvement upon available 
technology at the same cost " " " " 
Safe to use " " " " 
Durable " " " " 
Consistent " " " " 
Adaptable to varying power supplies N/A " N/A " 
Aesthetically pleasing " " " " 
Simple construction " ! " ! 
Stable in local environment " " " " 
Pr
og
ra
m
 
El
em
en
ts
 
Had previous design failure " ! " ! 
Pre-design data collection ! ! " " 
Laboratory testing ! " ! " 
Multisite implementation ! " ! " 
Phased implementation  ! ! " " 
Staff training ! ! " " 
Accounted for device delivery  ! ! N/A " 
Ev
al
ua
tio
n 
Quantitative data collection ! " " ! 
Qualitative data collection from staff ! " " " 
Qualitative data collection from 
patients ! ! ! ! 
Plans for future development ! ! ! ! 
Seek FDA/CE approval ! ! ! ! 
INPUTS ACTIVITIES OUTPUTS SHORT-TERM OUTCOMES 
LONG-TERM 
OUTCOMES 
IMPACTS 
In order to accomplish 
our set of activities we 
need the following:  
In order to address our 
problem we will 
accomplish the 
following activities: 
We expect that once 
accomplished the 
following will be 
evidence of service 
delivery: 
We expect that if 
accomplished these 
activities will lead to 
the following changes 
in 1-3 years: 
We expect that if 
accomplished these 
activities will lead to 
the following changes 
in 3-5 years: 
We expect that if 
accomplished these 
activities will lead to 
the following changes 
in 7-10 years: 
Project 
Manager 
Design Partner 
International 
Partner(s) 
Clinical  
Partner(s) 
Manufacturing 
Partner 
Advertising 
Partner 
Distribution 
Partner 
Funding Partner 
Design an 
device that is 
low-cost 
Show that the 
device is safe and 
effective 
Provide the 
device to low-
resource hospitals 
Write the grant 
Train local staff 
to use the device 
Budget the 
project 
Identify all of the 
necessary 
partnerships 
# of hospitals 
served 
# of children 
affected 
# of students 
participating 
Testing Results 
# of devices made 
Functioning 
device 
Complete 
development 
team 
Properly 
allocated 
resources 
Increased global 
awareness 
amongst 
engineering 
students 
At least 3-5 
hospitals using 
the device as a 
trial 
Improvement in 
the knowledge of 
neonatal 
management 
Published report 
about he success 
of Project Tiger 
Breath 
Increased 
newborn survival 
New projects 
from inspired 
engineering 
students 
At least 150 
hospitals using 
the device 
Intracountry 
training, provider 
to provider 
Increasingly 
improved 
newborn survival 
Sustainable 
production with 
costs=price 
Unknown effects 
of other students 
Reduced neonatal 
morality in 
supplied areas. 
Increased quality 
in other 
departments of 
low-resource 
hospitals 
Thousands of 
children that are 
alive that 
otherwise 
wouldn’t be. 
